Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Background Immunotherapies are becoming front-line treatments for many advanced cancers, and combinations of two or more therapies are beginning to be investigated. Based on their individual antitumor capabilities, we sought to determine whether combination oncolytic virus (OV) and radiation therapy...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2023-07-01
|
| シリーズ: | Journal for ImmunoTherapy of Cancer |
| オンライン・アクセス: | https://jitc.bmj.com/content/11/7/e006780.full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
